Diabetes is also a prolonged disorder of glucose metabolism and ought to be a genuine purpose for health, a heart condition, cardiomyopathy, cardiovascular disease and end-stage nephritic disease in the world, the one biggest reason behind preventable visual impairment, the main explanation behind non-traumatic lower-extremity amputation and the major reason behind premature mortality.
The Diabetes World 2020 conference, NewYork, USA will be covering diverse topics of Diabetes and Metabolic Disorder such as Type I & Type II Diabetes, Risk factors and related diseases of Diabetes, Gestational Diabetes, Diabetes Ophthalmology, Cardiovascular risk in Type 2 Diabetes, Stem Cell treatment for Type 2 Diabetes, Advanced Technologies to treat Diabetes, Medication, Herbal Therapy for Diabetes, Biomarker for Diabetes, Diabetic Foot and many more.
Learning is a never-ending process. We at Hilaris Conferences, will provide a unique platform for the learners, researchers, policymakers, and innovators to network and share knowledge. Hilaris Conferences will act as a bridge between the Academia & Industry to fill the knowledge gap and inspire young minds through its unique learning opportunities. Hilaris Conference will offer a huge opportunity to share creative ideas, and promote the collaborative research environment through its specially designed networking sessions for a challenging future. Hilaris Meetings will establish a strong base for researchers and learners in the journey of their lifelong quest for knowledge.
Hilaris Conferences is going to host International Conferences, Meetings, Workshops, Events, and Symposiums in the vast domains of Life Sciences, Clinical Science, Medical Science, Healthcare, Agriculture & Food, Pharmaceuticals, Environmental Sciences, and Applied Engineering, etc. We welcome you to be a part of the Hilaris Conference and share your knowledge for a glorious future. We seek the support of all the stakeholders to fulfill our vision "Join us as a Lerner and proceed as a Leader".
In USA Diabetes Market is growing rapidly and almost high on demand. According to IMARC, the United States diabetes market reached a value of US$ 45.4 Billion in 2018. According to the Centers for Disease Control and Prevention (CDC), more than 30 million adults have been diagnosed with diabetes or pre-diabetes in the United States. In 2018, the United States represented the third-largest diabetes patient pool owing to the increasing geriatric population and rising obesity levels. Apart from this, physical inactivity and unhealthy lifestyle have further contributed to the escalating diabetic population.
According to Mordor Intelligence, market intelligence and advisory firm in the USA: The USA diabetes devices market has been estimated to be valued at USD 15.9 billion in 2019, registering a CAGR of 9.17% during the forecast period (2019-2024).
-
Diabetes care devices are used to control glucose levels in the blood. The main types of diabetes care devices include glucose monitoring devices and management devices.
-
The continuous glucose monitoring devices are widely used, due to technological innovations.
-
The United States is among the top five countries, with the highest diabetic population. The country has close to 100 million adults, diabetic and pre-diabetic. About 9.5% of the total population of the country has diabetes. According to studies, diabetes is among the leading health epidemics in the country. WHO had concluded that, in 2015, diabetes was the seventh-leading cause for death in the United States.
There are plenty of large and small market players from the USA, which operate in most middle east and Africa diabetes market are: Abbott (USA), Bayer AG (Germany), Becton Dickinson and Company (USA), Johnson & Johnson Services, Inc. (USA), Merck & Co., Inc. (USA), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Roche Diabetes Care, Inc. (USA), Sanofi-Aventis U.S. LLC (US), Ypsomed (Switzerland).
-
Harvard University, USA
-
University of Cambridge, UK
-
Johns Hopkins University, USA
-
University of California, San Francisco, USA
-
UCL (University College London), UK
|
-
University of Oxford, UK
-
Stanford University, USA
-
University of California, Los Angeles (UCLA), USA
-
Yale University, USA
-
Karolinska Institutet, Sweden
|
-
Mayo Clinic (Rochester, MN)
-
Massachusetts General Hospital (Boston, MA)
-
UCSF Medical Center (San Francisco, CA)
-
Yale-New Haven Hospital (New Haven, CT)
-
UCLA Medical Center (Los Angeles, CA)
|
-
Cleveland Clinic (Cleveland, OH)
-
Johns Hopkins Hospital (Baltimore, MD)
-
New York-Presbyterian University Hospital of Weill Cornell (New York, NY)
-
Northwestern Memorial Hospital (Chicago, IL)
-
University of Washington Medical Center (Seattle, WA)
|
-
Pfizer
-
Sanofi
-
Merck & Co
-
AbbVie
-
GlaxoSmithKline (GSK)
|
-
Roche
-
Johnson & Johnson
-
Novartis
-
Gilead
-
Sciences Amgen
|
